Stock dilution

Third Quarter 2022: Increase in Reservations and Multiple International Partnerships Signed

Retrieved on: 
Thursday, December 8, 2022

In the third quarter of 2022, the Company’s proprietary solar technology continued to benefit from significant interest, which led to a further increase in customer arrangements.

Key Points: 
  • In the third quarter of 2022, the Company’s proprietary solar technology continued to benefit from significant interest, which led to a further increase in customer arrangements.
  • Compared to the third quarter of 2021, the Company signed an additional four letters of intent and 12 purchase orders.
  • Net loss totaled €43.5 million and €0.50 loss per share in the third quarter of 2022 (third quarter of 2021: €18.0 million and €0.29).
  • Subsequent to the third quarter of 2022, Sono Motors announced its partnerships with tier one automotive suppliers Bosch and Continental.

Activist investor David Kanen writes letter in response to EZPW news of convertible debt offering, excoriating Chairman Phillip Cohen

Retrieved on: 
Wednesday, December 7, 2022

AUSTIN, Texas, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The following is a statement issued by David Kanen, who serves as President of Kanen Wealth Management.

Key Points: 
  • AUSTIN, Texas, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The following is a statement issued by David Kanen, who serves as President of Kanen Wealth Management.
  • We are writing this letter in response to the announced ill-advised convertible debt offering this morning, and exhort you to rescind immediately.
  • The good news is, EZPW can “fix” a meaningful portion of its tenured history of epic underperformance by making simple changes.
  • FCFS has $1.37B in long-term gross debt at an average interest rate of ~5.7%, that is against ~$400M in EBITDA.

Americold Enters into Floating to Fixed Interest Rate Swaps

Retrieved on: 
Monday, December 5, 2022

(1) For the $200 million A-1 tranche, the Company has entered into two, separate interest rate swaps.

Key Points: 
  • (1) For the $200 million A-1 tranche, the Company has entered into two, separate interest rate swaps.
  • (4) Base Interest Rate Swap is the fixing of 1 month SOFR (USD tranches) and 1 month CDOR (CAD tranche) for the Effective Swap Dates.
  • (5) Contractual Interest Rate is the Base Interest Rate Swap plus Credit Spread (95 basis points, based on Americold’s current credit ratings) plus SOFR Adjustment (10 basis points, for USD tranches only).
  • Examples of forward-looking statements included in this document include, among others, statements about our plans and expectations regarding refinancing our CMBS debt, use of proceeds and hedging strategies, including entering into interest rate swaps to reduce floating rate debt exposure to historical levels.

Genius Sports Limited Announces Extension of Consent Solicitation Relating to Warrants

Retrieved on: 
Friday, December 16, 2022

Genius Sports Limited (NYSE: GENI) (Genius or the Company) today announced the extension of its previously-announced solicitation of consents (the Consent Solicitation) from holders of the Companys outstanding warrants.

Key Points: 
  • Genius Sports Limited (NYSE: GENI) (Genius or the Company) today announced the extension of its previously-announced solicitation of consents (the Consent Solicitation) from holders of the Companys outstanding warrants.
  • The Company has engaged BofA Securities, Inc. as the solicitation agent for the Consent Solicitation and the exercise of the warrants, including any subsequent amendments to the transaction structure.
  • The Consent Solicitation is being made only through the Schedule TO and prospectus and the complete terms and conditions of the Consent Solicitation are set forth in the Schedule TO and prospectus.
  • Holders of the warrants are urged to read the Schedule TO and prospectus carefully before making any decision with respect to the Consent Solicitation because they contain important information, including the various terms of, and conditions to, the Consent Solicitation.

NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today

Retrieved on: 
Thursday, December 15, 2022

NanoVibronix, Inc. (NASDAQ: NAOV) (the Company), a medical device company utilizing the Companys proprietary and patented low intensity surface acoustic wave (SAW) technology, announced that the Companys 2022 annual meeting of stockholders (the Annual Meeting) was held today virtually and broadcast live at www.virtualshareholdermeeting.com/NAOV2022 .

Key Points: 
  • NanoVibronix, Inc. (NASDAQ: NAOV) (the Company), a medical device company utilizing the Companys proprietary and patented low intensity surface acoustic wave (SAW) technology, announced that the Companys 2022 annual meeting of stockholders (the Annual Meeting) was held today virtually and broadcast live at www.virtualshareholdermeeting.com/NAOV2022 .
  • Ratification of the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
  • A proposal to approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1-5.
  • Investors and security holders are urged to read these documents free of charge on the SECs web site at: http://www.sec.gov .

Ericsson Capital Markets Day 2022

Retrieved on: 
Thursday, December 15, 2022

STOCKHOLM, Dec. 15, 2022 /PRNewswire/ --Ericsson (NASDAQ: ERIC) hosts a Capital Markets Day on December 15, 2022.

Key Points: 
  • STOCKHOLM, Dec. 15, 2022 /PRNewswire/ --Ericsson (NASDAQ: ERIC) hosts a Capital Markets Day on December 15, 2022.
  • Transforming Ericsson into a platform company creates a virtuous circle with new revenue streams for operators to monetize their network investments.
  • During 2022, there has been significant investments in working capital due to geo-resiliency as well as a tight supply chain.
  • Ericsson's Capital Markets Day event can be accessed via the Ericsson website: www.ericsson.com/en/investors/events-and-presentations/cmd
    Presentation materials can also be downloaded from the website once the webcast has started.

Ericsson Capital Markets Day 2022

Retrieved on: 
Thursday, December 15, 2022

STOCKHOLM, Dec. 15, 2022 /PRNewswire/ --Ericsson (NASDAQ: ERIC) hosts a Capital Markets Day on December 15, 2022.

Key Points: 
  • STOCKHOLM, Dec. 15, 2022 /PRNewswire/ --Ericsson (NASDAQ: ERIC) hosts a Capital Markets Day on December 15, 2022.
  • Transforming Ericsson into a platform company creates a virtuous circle with new revenue streams for operators to monetize their network investments.
  • During 2022, there has been significant investments in working capital due to geo-resiliency as well as a tight supply chain.
  • Ericsson's Capital Markets Day event can be accessed via the Ericsson website: www.ericsson.com/en/investors/events-and-presentations/cmd
    Presentation materials can also be downloaded from the website once the webcast has started.

SQN Sends Letter to Bigtincan Board Objecting to Rumored Capital Raise

Retrieved on: 
Wednesday, December 7, 2022

The full text of the letter sent to BTHs Board on December 7, 2022, follows.

Key Points: 
  • The full text of the letter sent to BTHs Board on December 7, 2022, follows.
  • And then suddenly you would choose to embark on this potentially dilutive and speculative capital raise?
  • Your potential transaction to raise A$30M for speculative acquisitions erodes value and is not in the best interests of shareholders.
  • We urge you to not pursue any capital raise or do any acquisitions at this time.

Manchester United PLC Reports First Quarter Fiscal 2023 Results

Retrieved on: 
Thursday, December 8, 2022

Total operating expenses for the quarter were 163.7 million, an increase of 9.6 million, or 6.2%, over the prior year quarter.

Key Points: 
  • Total operating expenses for the quarter were 163.7 million, an increase of 9.6 million, or 6.2%, over the prior year quarter.
  • Other operating expenses for the quarter were 37.8 million, an increase of 11.0 million, or 41.0%, over the prior year quarter.
  • Depreciation for the quarter was 3.5 million, a decrease of 0.2 million, or 5.4%, over the prior year quarter.
  • Overall, net finance costs for the quarter were 31.0 million, compared to 9.7 million in the prior year quarter.

Electromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022

Retrieved on: 
Monday, December 5, 2022

SCOTTSDALE, Ariz., Dec. 5, 2022 /PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, is pleased to provide its Financial and Operational Highlights for the three and nine months ended September 30, 2022.

Key Points: 
  • Electromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022
    SCOTTSDALE, Ariz., Dec. 5, 2022 /PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, is pleased to provide its Financial and Operational Highlights for the three and nine months ended September 30, 2022.
  • Highlights for the three and nine months ended Sep 30, 2022
    Strong net sales during the quarter totaling approximately $280,000, beating both Q1 and Q2 2022 sales.
  • Net loss for the nine months ended Sep 30, 2022, of $2.64 million, a 60% improvement over net loss for the nine months ended Sep 30, 2021.
  • Approximately $900K in net financing used to expedite development of the new WellnessPro Infinity Flagship Device.